Markets:

Overview

News

Currencies

International

Treasuries

Nektar Therapeutics - Common Stock (NQ:NKTR)

71.33 +0.33 (+0.46%)

Streaming Delayed Price Updated: 4:00 PM EST, Feb 13, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Nektar Therapeutics - Common Stock

< Previous 1 2 3 4 5 6 7 Next >

Expert Ratings for Nektar Therapeutics ↗

May 10, 2023

Via Benzinga

Nektar Therapeutics: Q1 Earnings Insights ↗

May 09, 2023

Via Benzinga

Analyst Says Nektar Therapeutics' Rezpeg Prioritization Likely to Spark Investor Questions ↗

April 18, 2023

Via Benzinga

7 Sorry Pharma Stocks to Sell in April Before It’s Too Late ↗

April 16, 2023

You have to be patient when investing in pharma stocks. But sometimes the risk and the wait aren't worth the rewards.

Via InvestorPlace

Analysts At H.C. Wainwright & Co. Set 12-Month Target Of $15 Per Share For ENLV Thanks To High Profile Collaboration Agreement, Multiple Ongoing Clinical Trials ↗

April 13, 2023

This month, H.C. Wainwright & Co.

Via Benzinga

Analyst Ratings for Nektar Therapeutics ↗

March 06, 2023

Via Benzinga

Nektar Therapeutics Earnings Perspective: Return On Capital Employed ↗

March 06, 2023

Via Benzinga

Stocks That Hit 52-Week Lows On Tuesday ↗

March 21, 2023

On Tuesday, 74 companies achieved new lows for the year.

Via Benzinga

Tesla To Rally Over 16%? Here Are 10 Other Analyst Forecasts For Monday ↗

March 06, 2023

Citigroup raised the price target for The Manitowoc Company, Inc. (NYSE: MTW) from $11 to $21. Citigroup analyst Timothy Thein maintained a Neutral rating. Manitowoc shares fell 2.4% to $19.09 in...

Via Benzinga

Stocks That Hit 52-Week Lows On Tuesday ↗

March 14, 2023

Tuesday's morning session saw 84 companies set new 52-week lows.

Via Benzinga

Dow Dips 350 Points; S&P 500 Down Over 1% ↗

February 24, 2023

U.S. stocks traded lower toward the end of trading, with the Dow Jones dropping over 300 points on Friday. The Dow traded down 1.07% to 32,798.91 while the NASDAQ fell 1.90% to 11,370.53. The S&P 500...

Via Benzinga

Stocks That Hit 52-Week Lows On Tuesday ↗

February 28, 2023

During Tuesday, 79 stocks hit new 52-week lows.

Via Benzinga

12 Health Care Stocks Moving In Friday's Intraday Session ↗

February 24, 2023

Via Benzinga

Why Fulcrum Therapeutics Shares Are Trading Lower By Over 55%? Here Are Other Stocks Moving In Friday's Mid-Day Session ↗

February 24, 2023

Gainers Bridger Aerospace Group Holdings, Inc. (NASDAQ: BAER) shares jumped 129.6% to $10.15. Jeffrey E. Kelter reported a 22.4% stake in a 13D filing on Thursday.

Via Benzinga

Nasdaq Tumbles 2%; Timber Pharmaceuticals Shares Spike Higher ↗

February 24, 2023

U.S. stocks traded lower midway through trading, with the Dow Jones dropping over 450 points on Friday. The Dow traded down 1.39% to 32,692.94 while the NASDAQ fell 2.14% to 11,342.36. The S&P 500 also...

Via Benzinga

Benzinga's Top Ratings Upgrades, Downgrades For February 24, 2023 ↗

February 24, 2023

Via Benzinga

US Stocks Open Lower; Dow Drops 1% ↗

February 24, 2023

U.S. stocks traded lower this morning, with the Dow Jones dropping over 150 points on Friday. Following the market opening Friday, the Dow traded down 1.05% to 32,807.33 while the NASDAQ fell 1.52% to...

Via Benzinga

PIXY Stock Alert: What to Know as ShiftPixy Utilizes ChatGPT for Recruiting ↗

February 24, 2023

ShiftPixy (PIXY) stock is on the move Friday after the company announced plans to use ChatGPT for recruiting and hiring.

Via InvestorPlace

BA Stock Alert: Boeing Halts Deliveries of 787 Dreamliners ↗

February 24, 2023

Boeing (BA) stock is a hot topic among traders on Friday after the aerospace company halted deliveries of its 787 Dreamliner.

Via InvestorPlace

Why Is Nektar Therapeutics (NKTR) Stock Down 39% Today? ↗

February 24, 2023

Nektar Therapeutics (NKTR) stock is taking a beating on Friday following the release of poor Phase 2 clinical trial data.

Via InvestorPlace

Why Nektar Therapeutics Stock Is Plunging Today ↗

February 24, 2023

Via Benzinga

12 Health Care Stocks Moving In Friday's Pre-Market Session ↗

February 24, 2023

Via Benzinga

Why Beyond Meat Shares Are Trading Higher By 14%; Here Are 20 Stocks Moving Premarket ↗

February 24, 2023

Gainers Cingulate Inc (NASDAQ: CING) rose 85.7% to $2.08 in pre-market trading after the company disclosed top-line results from Fed/Fast study of lead asset CTx-1301 for ADHD.

Via Benzinga

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday ↗

February 24, 2023

It's time to start off trading on Friday with a breakdown of the biggest pre-market stock movers worth keeping an eye on!

Via InvestorPlace

US Stocks Stare At More Losses In a Lackluster Week: Can Inflation Data Salvage Year's Rally? ↗

February 24, 2023

See-sawing sentiment continues to persist on Wall Street, as index futures signal weakness on Friday after Thursday's positive close. A key inflation reading due ahead of the market opening may largely...

Via Benzinga

BigCommerce, ContextLogic And Other Big Stocks Moving Lower In Friday's Pre-Market Session ↗

February 24, 2023

U.S. stock futures traded lower this morning. Here are some big stocks recording losses in today’s pre-market trading session.

Via Benzinga

Glancy Prongay & Murray LLP Announces Investigation of Nektar Therapeutics (NKTR)

February 01, 2023

From Glancy Prongay & Murray LLP

Via Business Wire

12 Health Care Stocks Moving In Tuesday's After-Market Session ↗

November 29, 2022

Via Benzinga

Stocks That Hit 52-Week Lows On Friday ↗

December 23, 2022

OnFriday, 143 stocks hit new 52-week lows.

Via Benzinga

Stocks That Hit 52-Week Lows On Wednesday ↗

November 30, 2022

During Wednesday's session, 107 stocks hit new 52-week lows.

Via Benzinga

< Previous 1 2 3 4 5 6 7 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.

Nektar Therapeutics - Common Stock (NQ:NKTR)

All News about Nektar Therapeutics - Common Stock

Starting at $3.75/week.

Subscribe Today